Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15215619rdf:typepubmed:Citationlld:pubmed
pubmed-article:15215619lifeskim:mentionsumls-concept:C0026912lld:lifeskim
pubmed-article:15215619lifeskim:mentionsumls-concept:C0442118lld:lifeskim
pubmed-article:15215619lifeskim:mentionsumls-concept:C0020522lld:lifeskim
pubmed-article:15215619lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15215619lifeskim:mentionsumls-concept:C1817908lld:lifeskim
pubmed-article:15215619lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:15215619lifeskim:mentionsumls-concept:C0008357lld:lifeskim
pubmed-article:15215619lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:15215619pubmed:issue6lld:pubmed
pubmed-article:15215619pubmed:dateCreated2004-6-24lld:pubmed
pubmed-article:15215619pubmed:abstractTextRecombinant cholera toxin B subunit (rCTB) is a safe and potent mucosal adjuvant. To gain insight into the mechanism underlying the adjuvant effect of rCTB, the effects of rCTB on cell-mediated immune responses of mice and guinea pigs were examined after intranasal administration of Mycobacterium bovis -bacillus Calmette-Guérin (BCG) with and without rCTB. Delayed-type hypersensitivity, for skin reactions in guinea pigs and for footpad swelling reactions in mice, to purified protein derivative (PPD) were enhanced by intranasal co-administration of BCG and rCTB, as compared to giving BCG alone to these animals. Moreover, tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma production of spleen cells and antigen specific spleen cell proliferation, stimulated with PPD, were enhanced in the presence of rCTB. These results strongly suggest that rCTB enhances cellular as well as humoral immune responses.lld:pubmed
pubmed-article:15215619pubmed:languageenglld:pubmed
pubmed-article:15215619pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15215619pubmed:citationSubsetIMlld:pubmed
pubmed-article:15215619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15215619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15215619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15215619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15215619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15215619pubmed:statusMEDLINElld:pubmed
pubmed-article:15215619pubmed:issn0385-5600lld:pubmed
pubmed-article:15215619pubmed:authorpubmed-author:TochikuboKuni...lld:pubmed
pubmed-article:15215619pubmed:authorpubmed-author:YamamotoSabur...lld:pubmed
pubmed-article:15215619pubmed:authorpubmed-author:IsakaMasanori...lld:pubmed
pubmed-article:15215619pubmed:authorpubmed-author:YasudaYokoYlld:pubmed
pubmed-article:15215619pubmed:authorpubmed-author:MatanoKeikoKlld:pubmed
pubmed-article:15215619pubmed:authorpubmed-author:MorokumaKazun...lld:pubmed
pubmed-article:15215619pubmed:authorpubmed-author:OhkumaKunioKlld:pubmed
pubmed-article:15215619pubmed:authorpubmed-author:GotoNorihisaNlld:pubmed
pubmed-article:15215619pubmed:authorpubmed-author:MaeyamaJun-Ic...lld:pubmed
pubmed-article:15215619pubmed:issnTypePrintlld:pubmed
pubmed-article:15215619pubmed:volume48lld:pubmed
pubmed-article:15215619pubmed:ownerNLMlld:pubmed
pubmed-article:15215619pubmed:authorsCompleteYlld:pubmed
pubmed-article:15215619pubmed:pagination457-63lld:pubmed
pubmed-article:15215619pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:meshHeadingpubmed-meshheading:15215619...lld:pubmed
pubmed-article:15215619pubmed:year2004lld:pubmed
pubmed-article:15215619pubmed:articleTitleEffects of recombinant cholera toxin b subunit (rCTB) on cellular immune responses: enhancement of delayed-type hypersensitivity following intranasal co-administration of Mycobacterium bovis-BCG with rCTB.lld:pubmed
pubmed-article:15215619pubmed:affiliationDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan. meymj@nih.go.jplld:pubmed
pubmed-article:15215619pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15215619pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15215619pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15215619lld:pubmed